7.2138
price down icon7.12%   -0.5462
 
loading

Finanzdaten der Journey Medical Corp-Aktie (DERM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
17.47%
17.63
15.01 13.14 13.62 14.63
Operating Expenses
7.13%
19.16
17.89 16.46 9.149 12.24
Benefits Costs and Expenses
6.41%
19.95
18.75 17.21 12.04 17.02
Costs And Expenses
7.13%
19.16
17.89 16.46 11.39 17.52
Operating Income/Loss
46.84%
-1.529
-2.876 -3.324 2.234 -2.894
Nonoperating Income/Loss
8.60%
-0.786
-0.86 -0.749 -0.652 0.504
Income/Loss From Continuing Operations Before Tax
38.04%
-2.315
-3.736 -4.073 1.582 -2.39
Income Tax Expense/Benefit
100.00%
-
0.06 - - -
Income/Loss From Continuing Operations After Tax
39.01%
-2.315
-3.796 -4.073 1.521 -2.39
Net Income/Loss
39.01%
-2.315
-3.796 -4.073 1.521 -2.39
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7.16%
24.96
23.29 22.61 0.2935 20.54
Diluted Average Shares
7.16%
24.96
23.29 22.61 0.2935 20.54
Basic Earnings Per Share
43.75%
-0.09
-0.16 -0.18 0.08 -0.12
Diluted Earnings Per Share
43.75%
-0.09
-0.16 -0.18 0.08 -0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.84
price up icon 0.66%
drug_manufacturers_specialty_generic RGC
$23.30
price up icon 0.00%
drug_manufacturers_specialty_generic RDY
$14.18
price down icon 1.22%
$130.01
price up icon 1.75%
$13.86
price up icon 0.90%
$537.49
price up icon 1.12%
Kapitalisierung:     |  Volumen (24h):